Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15762773 | 1.00 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL12337349 | 0.98 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL14099672 | 0.98 | ESR1 (0.41) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL19621666 | 0.98 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL14099685 | 0.98 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL12014679 | 0.98 | ESR1 (0.40) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL13333898 | 0.97 | ESR1 (0.38) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL20130972 | 0.97 | ESR1 (0.41) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL14424680 | 0.97 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 | |
| SCHEMBL14867158 | 0.97 | ESR1 (0.39) | ESR1ESR2HSD17B1HSD17B2CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2730634-B1 | NOVEL COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2019-10-09 | — | — | EP | disclosed |
| US-9000169-B2 | Compounds and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-04-07 | — | — | US | disclosed |
| US-9000169-B2 | Compounds and organic electronic device using the same | LG CHEM, LTD. (KR) | 2015-04-07 | — | — | US | disclosed |
| US-8647753-B2 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2014-02-11 | — | — | US | disclosed |
| US-8647753-B2 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2014-02-11 | — | — | US | disclosed |
| US-20130181196-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2013-07-18 | — | — | US | disclosed |
| US-20130181196-A1 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2013-07-18 | — | — | US | disclosed |
| WO-2013009013-A2 | NOVEL COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME | 주식회사 엘지화학 (KR) | 2013-01-17 | — | — | WO | disclosed |
| US-8137823-B2 | Anthracene derivatives, process for preparation thereof, and organic electronic light emitting device using the same | LG CHEM, LTD. (KR) | 2012-03-20 | — | — | US | disclosed |
| US-7906228-B2 | Compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2011-03-15 | — | — | US | disclosed |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | GRACEL DISPLAY INC. (KR) | 2009-06-11 | — | — | US | disclosed |
| EP-2060579-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-20 | — | — | EP | disclosed |
| EP-2058322-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-13 | — | — | EP | disclosed |
| EP-2055710-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-06 | — | — | EP | disclosed |
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2009-03-26 | — | — | US | disclosed |
| US-20070087222-A1 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2007-04-19 | — | — | US | disclosed |
| US-20070087222-A1 | Organic electroluminescence device | LG DISPLAY CO., LTD. (KR) | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090145483-A1 | Novel electroluminescent compounds and organic electroluminescent device suing the same | LEF1, ODC1, AOC2 | ESR1 434/4885ESR2 777/4885HSD17B1 2583/4885 |
| US-20090153040-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, APOL1 | ESR1 548/4885ESR2 975/4885HSD17B1 1314/4885 |
| US-20090079334-A1 | Novel Anthracene Derivatives, Process for Preparation Thereof, and Organic Electronic Light Emitting Device Using the Same | XPOT, ALAD, APRT | ESR1 143/4885ESR2 1238/4885HSD17B1 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.